Partnerships
Agreement with Helmholtz Centre for Infection Research
By Melanie Berg – Nov. 30, 2020 Pharmacelera is proud to announce
November 30, 2020
No Comments
Menu
By Melanie Berg – Nov. 30, 2020 Pharmacelera is proud to announce
By Lluis Campos – Sep. 23, 2020 Molecular Docking is a key
We are happy to announce that PharmScreen, our virtual screening tool is
The Severe Acute Respiratory Syndrome coronavirus 2 (SARS-CoV-2) or COVID-19 has spread
2019 was an exciting year for Pharmacelera and we look forward to
By Javier Vazquez – Dec. 11, 2019 Virtual Screening (VS) is a
Researchers at Bellvitge Biomedical Research Institute will develop a research project with
PharmScreen evolves day by day thanks to the feedback of many computational
Why protein-protein interactions are important? Protein-protein interactions (PPI) play a major role
Today, the amount of data generated in many fields such as engineering,
CCDC and Pharmacelera combine virtual screening and machine learning expertise to help
The Universitat Autònoma de Barcelona (UAB) and Pharmacelera have reached an agreement
Last December, Biocat 1 reported that the Bioregion of Catalonia is witnessing a
Pharmacelera has been awarded an SME Phase I grant from the European
The Spanish National Research Centre (CNIO) is a Spanish public institution focused
For most of the past decade, the number of drugs approved every